New #TrinityResearch from @tcdgenmicro involving a novel gene therapeutic approach shows promise for treating age related macular degeneration (#AMD) and other eye conditions such as #glaucoma.
Read more at: https://t.co/O7Y6IQY8iQ
Age-related macular degeneration (AMD) affects up to 10% of adults over the age of 65.
@VzariiTX has developed first in class innovative platform gene therapies that target late-stage dry AMD to restore mitochondrial disfunction and improve retinol function.
#BigIdeas2022
Age-related macular degeneration (AMD) is a neurodegenerative retinal disease affecting up to 10% of adults over 65 years. At BIG IDEAS β 24 November hear how Vzarii has developed innovative gene therapies that target late-stage dry AMD @Entirl#GLOBALAMBITION
Last talk of the day from @benshaberman from @FightBlindness at #RetinaDublin Scientific Day. Ben is delivering a talk on the latest updates in clinical research for inherited retinal diseases.
Exciting new gene therapy shows promise for treating Age-related Macular Degeneration (AMD) β a progressive eye disease that affects up to 10% of adults over 65 and is a leading cause of severe vision impairment and blindness https://t.co/5TrlXYNXvP
Listening to #nigeltopping 4 good reasons to drive sustainability and #RaceToZero cost reduction, market share growth, talent reduction and driving innovation
.@JPowerChiefEcon is now providing an update on the international & domestic context, noting where we currently stand, and what this means for the economy. Sponsored by @Accenture_Irl. #IoDevents
@HealthIreland listening to Tanya Mulvany at #Healthinnovationhubireland showcasing the numerous submissions to its solutions Portal during 2020 50% IT/#digital and a reminder of importance of need budget and #culture to implement
We are exceeding Ecological &Social Foundation barriers & donβt know what will happen next - listening to #ESGandtheBoard@IoDIreland @BITCIreland